ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,815Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 2343

$2.31M Total Retail Price of All Prescriptions

Rank: 4 out of 2343

682 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 682 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 682 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 18,235 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 1,136 773 1 4
SIMVASTATIN 1,077 724 2 1
ENDOCET 1,021 497 S2 10 3 97
ZOLPIDEM TARTRATE 846 544 4 24
LISINOPRIL 783 575 5 3
METFORMIN HCL 587 364 6 9
LEVOTHYROXINE SODIUM 530 396 7 2
CRESTOR 490 378 8 30
CARVEDILOL 486 343 9 27
RANITIDINE HCL 419 220 10 43
DIOVAN 412 349 11 23
FUROSEMIDE 403 337 12 6
ATORVASTATIN CALCIUM 370 303 13 10
AMLODIPINE BESYLATE 363 279 14 5
CLOPIDOGREL 330 283 15 26
SERTRALINE HCL 312 196 16 20
GABAPENTIN 306 183 17 16
NEXIUM 295 104 18 33
METOPROLOL TARTRATE 271 196 19 7
DIOVAN HCT 268 161 20 63
VENTOLIN HFA 265 125 21 79
LEVEMIR FLEXPEN 253 152 22 218
TAMSULOSIN HCL 251 200 23 29
JANUVIA 246 193 24 50
PLAVIX 243 212 25 38
FLUTICASONE PROPIONATE 243 109 25 46
CLOTRIMAZOLE-BETAMETHASONE 237 151 27 127
LYRICA 236 99 28 135
SINGULAIR 235 117 29 100
PRAVASTATIN SODIUM 233 190 30 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 232 175 31 42
VICTOZA 3-PAK 230 60 32 407
AMITRIPTYLINE HCL 230 141 R 32 117
DONEPEZIL HCL 224 211 34 21
METOPROLOL SUCCINATE 222 179 35 14
LOVAZA 216 137 36 113
HYDROCHLOROTHIAZIDE 215 129 37 11
LOSARTAN POTASSIUM 209 174 38 19
HYDROCODONE-ACETAMINOPHEN 206 128 S3 39 13
ACTOPLUS MET 206 129 10 39 346
IBUPROFEN 196 98 41 75
LANTUS SOLOSTAR 194 108 42 101
TRAMADOL HCL 190 105 43 25
ACTOS 180 147 44 125
AZITHROMYCIN 176 104 45 39
NAMENDA 176 168 45 36
ADVAIR DISKUS 175 139 47 34
JANUMET 173 137 48 191
PANTOPRAZOLE SODIUM 169 124 49 22
CYCLOBENZAPRINE HCL 167 43 R 50 109
WARFARIN SODIUM 166 117 51 8
ADVAIR HFA 165 40 52 376
SPIRIVA 164 125 53 48
TRICOR 162 114 54 96
PEN NEEDLE 158 106 55 119
CITALOPRAM HBR 156 72 56 17
GLIMEPIRIDE 156 110 56 45
NASONEX 149 84 58 209
ACETAMINOPHEN-CODEINE 149 95 S3 58 112
EXFORGE 141 80 60 163
METFORMIN HCL ER 131 66 61 88
LOVASTATIN 131 110 61 47
CYMBALTA 126 54 63 74
COREG CR 122 87 64 301
AVODART 121 101 65 165
MONTELUKAST SODIUM 119 56 66 181
BYSTOLIC 111 86 67 123
POTASSIUM CHLORIDE 110 79 68 18
OXYCODONE-ACETAMINOPHEN 110 52 S2 68 49
CIPROFLOXACIN HCL 110 81 68 72
NAPROXEN 107 68 71 108
LOSARTAN-HYDROCHLOROTHIAZIDE 103 70 72 64
ZETIA 101 85 73 52
MECLIZINE HCL 101 81 73 103
RISPERIDONE 99 55 75 61
JANUMET XR 97 75 10 76 490
CARAFATE 93 63 77 315
TRIAMCINOLONE ACETONIDE 86 68 78 137
HUMALOG 83 63 79 131
SEROQUEL XR 82 59 80 420
POLYETHYLENE GLYCOL 3350 82 55 80 54
CELEBREX 81 71 82 71
AMLODIPINE BESYLATE-BENAZEPRIL 81 66 82 59
AGGRENOX 81 58 82 174
KLOR-CON 10 78 56 85 134
MEGESTROL ACETATE 77 67 R 86 246
PREDNISONE 75 44 87 37
CLOBETASOL PROPIONATE 75 41 87 263
TOPIRAMATE 75 11 87 220
NOVOLOG FLEXPEN 74 24 90 212
EXELON 73 65 91 129
AMITIZA 72 41 92 304
GLIPIZIDE 71 51 93 56
PIOGLITAZONE-METFORMIN 70 50 R 94 515
PAROXETINE HCL 69 34 95 66
TRAZODONE HCL 69 16 95 53
PIOGLITAZONE HCL 68 50 R 97 347
VALSARTAN-HYDROCHLOROTHIAZIDE 66 40 98 320
METHYLPREDNISOLONE 64 30 99 122
SYMBICORT 63 50 100 167
FORTEO 63 61 100 375
ISOSORBIDE MONONITRATE ER 62 52 102 32
UNIFINE PENTIPS 61 26 103 454
TRAMADOL HCL-ACETAMINOPHEN 61 48 103 199
VENLAFAXINE HCL ER 60 17 105 87
KLOR-CON M10 59 52 106 107
NABUMETONE 59 41 106 259
PROPRANOLOL HCL 58 43 108 132
TIZANIDINE HCL 56 38 109 296
DIGOXIN 56 46 109 35
CIPRODEX 55 27 111 558
NIFEDIPINE ER 53 50 112 89
QUETIAPINE FUMARATE 52 25 113 77
AMOXICILLIN 51 38 114 118
DIPHENOXYLATE-ATROPINE 50 28 115 329
FINASTERIDE 50 36 115 80
METOCLOPRAMIDE HCL 50 16 115 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.